Ed Arce
Stock Analyst at Westpark Capital
(4.86)
# 369
Out of 4,579 analysts
1071
Total ratings
48.8%
Success rate
22.9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Ed Arce
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TLPH Talphera | Initiated Coverage: Buy | $6 → $3 | $1.26 | +138.10% | 88 | Apr 30, 2026 | |
| MTVA MetaVia | Maintained: Buy | $132 | $1.45 | +9,003.45% | 9 | Sep 17, 2025 | |
| ARCT Arcturus Therapeutics Holdings | Maintained: Buy | $60 | $5.76 | n/a | 72 | Apr 11, 2025 | |
| UNCY Unicycive Therapeutics | Maintained: Buy | $75 | $5.13 | n/a | 33 | Apr 11, 2025 | |
| AKBA Akebia Therapeutics | Maintained: Buy | $7.5 | $1.28 | n/a | 85 | Apr 4, 2025 | |
| IVA Inventiva | Reiterated: Buy | $13 | $4.60 | n/a | 32 | Apr 3, 2025 | |
| GALT Galectin Therapeutics | Maintained: Hold | n/a | $3.38 | n/a | 56 | Apr 2, 2025 | |
| ALGS Aligos Therapeutics | Maintained: Buy | $70 | $4.08 | n/a | 6 | Mar 31, 2025 | |
| ASMB Assembly Biosciences | Maintained: Hold | n/a | $25.91 | n/a | 30 | Mar 21, 2025 | |
| ACXP Acurx Pharmaceuticals | Reiterated: Buy | $240 | $1.43 | n/a | 21 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1.08 | n/a | 36 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 | $7.45 | n/a | 10 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $400 → $405 | $551.25 | n/a | 42 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $66 → $72 | $114.20 | n/a | 60 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5.5 | $5.06 | n/a | 13 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $95 | $26.89 | n/a | 10 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 | $12.73 | n/a | 16 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $4.41 | n/a | 37 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 → $22 | $56.68 | n/a | 26 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $48 | $30.22 | n/a | 2 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $0.031 | n/a | 44 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 | $15.22 | n/a | 90 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.669764 | n/a | 12 | Apr 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $120 | $0.116 | n/a | 7 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 | $35.18 | n/a | 12 | Jan 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.527 | n/a | 39 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 51 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $13.11 | n/a | 13 | Dec 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.28672 | n/a | 33 | Nov 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $13.64 | n/a | 3 | May 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €12.00 | €3.92 | n/a | 15 | Mar 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $29 → $31 | $35.52 | n/a | 11 | Feb 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.3898 | n/a | 5 | Nov 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $27 | $1.18 | n/a | 5 | Aug 12, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1.25 | $0.011 | n/a | 14 | Mar 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $7 | $34.87 | n/a | 2 | Nov 28, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.4501 | n/a | 8 | Nov 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $0.0001 | n/a | 1 | Jan 30, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $9.58 | n/a | 12 | Jan 26, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7.5 → $5 | $0.0001 | n/a | 8 | Jan 9, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $0.5 | $0.001 | n/a | 2 | Mar 19, 2013 |
Talphera
Apr 30, 2026
Initiated Coverage: Buy
Price Target: $6 → $3
Current: $1.26
Upside: +138.10%
MetaVia
Sep 17, 2025
Maintained: Buy
Price Target: $132
Current: $1.45
Upside: +9,003.45%
Arcturus Therapeutics Holdings
Apr 11, 2025
Maintained: Buy
Price Target: $60
Current: $5.76
Upside: n/a
Unicycive Therapeutics
Apr 11, 2025
Maintained: Buy
Price Target: $75
Current: $5.13
Upside: n/a
Akebia Therapeutics
Apr 4, 2025
Maintained: Buy
Price Target: $7.5
Current: $1.28
Upside: n/a
Inventiva
Apr 3, 2025
Reiterated: Buy
Price Target: $13
Current: $4.60
Upside: n/a
Galectin Therapeutics
Apr 2, 2025
Maintained: Hold
Price Target: n/a
Current: $3.38
Upside: n/a
Aligos Therapeutics
Mar 31, 2025
Maintained: Buy
Price Target: $70
Current: $4.08
Upside: n/a
Assembly Biosciences
Mar 21, 2025
Maintained: Hold
Price Target: n/a
Current: $25.91
Upside: n/a
Acurx Pharmaceuticals
Mar 20, 2025
Reiterated: Buy
Price Target: $240
Current: $1.43
Upside: n/a
Mar 18, 2025
Maintained: Hold
Price Target: n/a
Current: $1.08
Upside: n/a
Mar 11, 2025
Maintained: Buy
Price Target: $32
Current: $7.45
Upside: n/a
Feb 27, 2025
Maintained: Buy
Price Target: $400 → $405
Current: $551.25
Upside: n/a
Feb 27, 2025
Maintained: Buy
Price Target: $66 → $72
Current: $114.20
Upside: n/a
Feb 20, 2025
Maintained: Hold
Price Target: $5.5
Current: $5.06
Upside: n/a
Feb 18, 2025
Maintained: Buy
Price Target: $95
Current: $26.89
Upside: n/a
Feb 10, 2025
Maintained: Buy
Price Target: $18
Current: $12.73
Upside: n/a
Jan 21, 2025
Maintained: Buy
Price Target: $5
Current: $4.41
Upside: n/a
Jan 14, 2025
Maintained: Buy
Price Target: $18 → $22
Current: $56.68
Upside: n/a
Jan 14, 2025
Maintained: Buy
Price Target: $48
Current: $30.22
Upside: n/a
Sep 10, 2024
Maintained: Buy
Price Target: $5
Current: $0.031
Upside: n/a
Sep 5, 2024
Maintained: Buy
Price Target: $13
Current: $15.22
Upside: n/a
Apr 24, 2024
Rated: Hold
Price Target: n/a
Current: $0.669764
Upside: n/a
Mar 26, 2024
Maintained: Buy
Price Target: $120
Current: $0.116
Upside: n/a
Jan 25, 2024
Maintained: Buy
Price Target: $25
Current: $35.18
Upside: n/a
Mar 27, 2023
Rated: Hold
Price Target: n/a
Current: $0.527
Upside: n/a
Mar 27, 2023
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Dec 21, 2021
Maintained: Hold
Price Target: n/a
Current: $13.11
Upside: n/a
Nov 29, 2021
Maintained: Hold
Price Target: n/a
Current: $0.28672
Upside: n/a
May 12, 2020
Downgraded: Hold
Price Target: n/a
Current: $13.64
Upside: n/a
Mar 18, 2020
Maintained: Buy
Price Target: €12.00
Current: €3.92
Upside: n/a
Feb 7, 2020
Maintained: Buy
Price Target: $29 → $31
Current: $35.52
Upside: n/a
Nov 11, 2019
Maintained: Hold
Price Target: n/a
Current: $0.3898
Upside: n/a
Aug 12, 2019
Maintained: Buy
Price Target: $27
Current: $1.18
Upside: n/a
Mar 14, 2019
Maintained: Hold
Price Target: $1.25
Current: $0.011
Upside: n/a
Nov 28, 2017
Rated: Buy
Price Target: $7
Current: $34.87
Upside: n/a
Nov 6, 2017
Maintained: Hold
Price Target: n/a
Current: $0.4501
Upside: n/a
Jan 30, 2015
Reiterated: Buy
Price Target: $5
Current: $0.0001
Upside: n/a
Jan 26, 2015
Maintained: Buy
Price Target: $20
Current: $9.58
Upside: n/a
Jan 9, 2015
Reiterated: Buy
Price Target: $7.5 → $5
Current: $0.0001
Upside: n/a
Mar 19, 2013
Downgraded: Sell
Price Target: $0.5
Current: $0.001
Upside: n/a